Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol for prevention of emergence delirium after sevoflurane anesthesia in children undergoing MRI
ACTRN12610000025033Phase 4Recruiting
- Sponsor
- Women's and Children's Hospital
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol in Emergence agitation (EA) (2 arms), sponsored by Women's and Children's Hospital. Primary endpoint: Incidence of emergence delirium. Started Jan 2010; status: recruiting.
02
Drugs
propofol
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ACTRN12610000025033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000025033.